EA200201059A1 - Препараты, содержащие глюкокортикостероидное лекарственное средство, для лечения бронхолегочных заболеваний - Google Patents

Препараты, содержащие глюкокортикостероидное лекарственное средство, для лечения бронхолегочных заболеваний

Info

Publication number
EA200201059A1
EA200201059A1 EA200201059A EA200201059A EA200201059A1 EA 200201059 A1 EA200201059 A1 EA 200201059A1 EA 200201059 A EA200201059 A EA 200201059A EA 200201059 A EA200201059 A EA 200201059A EA 200201059 A1 EA200201059 A1 EA 200201059A1
Authority
EA
Eurasian Patent Office
Prior art keywords
glukorticosteroidic
bronchopulmants
medicinal
diseases
treatment
Prior art date
Application number
EA200201059A
Other languages
English (en)
Inventor
Дейвид Льюис
Дейвид Гандертон
Брайан Микин
Гаэтано Брамбилла
Алессандра Феррарис
Original Assignee
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. filed Critical КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Publication of EA200201059A1 publication Critical patent/EA200201059A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Abstract

Настоящее изобретение описывает препараты для введения посредством дозированных аэрозольных ингаляторов под давлением, содержащих в качестве активного ингредиента глюкокортикоид, в частности (22R) эпимер будесонида в растворе в гидрофторуглеродном пропелленте, сорастворитель и подходящую добавку, и их применение для лечения астмы и других бронхолегочных расстройств.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200201059A 2000-05-12 2001-05-08 Препараты, содержащие глюкокортикостероидное лекарственное средство, для лечения бронхолегочных заболеваний EA200201059A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI001051A IT1318514B1 (it) 2000-05-12 2000-05-12 Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
PCT/EP2001/005211 WO2001085174A1 (en) 2000-05-12 2001-05-08 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases

Publications (1)

Publication Number Publication Date
EA200201059A1 true EA200201059A1 (ru) 2003-04-24

Family

ID=11445031

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200201059A EA200201059A1 (ru) 2000-05-12 2001-05-08 Препараты, содержащие глюкокортикостероидное лекарственное средство, для лечения бронхолегочных заболеваний

Country Status (21)

Country Link
US (1) US20030190289A1 (ru)
EP (1) EP1280532A1 (ru)
JP (1) JP2004515454A (ru)
AR (1) AR028448A1 (ru)
AU (1) AU2001258395A1 (ru)
BG (1) BG107257A (ru)
CA (1) CA2408647A1 (ru)
CZ (1) CZ20023717A3 (ru)
EA (1) EA200201059A1 (ru)
EE (1) EE200200632A (ru)
HR (1) HRP20020893A2 (ru)
HU (1) HUP0302036A2 (ru)
IT (1) IT1318514B1 (ru)
MA (1) MA26899A1 (ru)
MX (1) MXPA02011132A (ru)
NO (1) NO20025394L (ru)
PE (1) PE20011271A1 (ru)
PL (1) PL366212A1 (ru)
SK (1) SK16062002A3 (ru)
TN (1) TNSN01071A1 (ru)
WO (1) WO2001085174A1 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
AU5070100A (en) * 2000-05-22 2001-12-03 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
PT1273292E (pt) * 2001-07-02 2004-10-29 Chiesi Farma Spa Formulacao optimizada de tobramicina para aerossolizacao
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
BRPI0308274B8 (pt) * 2002-03-01 2021-05-25 Chiesi Farm Spa formulação de formoterol superfino
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
KR20180091120A (ko) * 2010-07-16 2018-08-14 시플라 리미티드 Ｒ　(＋)　부데소나이드 및 1종 이상의 기관지확장제를 포함하는 약학 조성물
US20160151275A1 (en) * 2014-06-16 2016-06-02 James Kevin Shurtleff Method and devices for manufacturing and delivering of aerosolized formulations

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) * 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) * 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en) * 1985-01-03 1986-04-22 David Rubin Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
DE59209686D1 (de) * 1991-08-29 1999-06-02 Broncho Air Medizintechnik Ag Medizinisches gerät zur inhalation von dosier-aerosolen
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
DE69324161T2 (de) * 1992-12-09 1999-10-28 Boehringer Ingelheim Pharma Stabilisierte medizinische aerosollösungen
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
AU4066693A (en) * 1992-12-23 1994-07-19 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
WO1995017195A1 (en) * 1993-12-20 1995-06-29 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
DE69636757T2 (de) * 1995-04-14 2007-10-11 Smithkline Beecham Corp. Dosierinhalator für Fluticasonepropionat
CZ292578B6 (cs) * 1995-04-14 2003-10-15 Glaxo Wellcome Inc. Inhalátor, inhalační systém
RO119116B1 (ro) * 1995-04-14 2004-04-30 Glaxo Wellcome Inc. Inhalator pentru dozarea salmeterolului
TR199701170T1 (xx) * 1995-04-14 1998-02-21 Glaxo Wellcome Inc. Beklometazon dipropionat i�in �l��lm�� doz inhaleri.
JP2728057B2 (ja) * 1995-10-30 1998-03-18 日本電気株式会社 光ディスク用情報アクセス装置
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
US6045784A (en) * 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
WO2000006121A1 (de) * 1998-07-24 2000-02-10 Jago Research Ag Medizinische aerosolformulierungen
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
ATE382386T1 (de) * 1998-11-13 2008-01-15 Jagotec Ag Multidosis-trockenpulverinhalator mit pulverreservoir
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6290930B1 (en) * 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
EP1158958B1 (en) * 1999-03-05 2007-06-06 CHIESI FARMACEUTICI S.p.A. Improved powdery pharmaceutical compositions for inhalation
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
AU5070100A (en) * 2000-05-22 2001-12-03 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
BRPI0308274B8 (pt) * 2002-03-01 2021-05-25 Chiesi Farm Spa formulação de formoterol superfino

Also Published As

Publication number Publication date
EP1280532A1 (en) 2003-02-05
US20030190289A1 (en) 2003-10-09
PE20011271A1 (es) 2002-01-11
CZ20023717A3 (cs) 2003-04-16
CA2408647A1 (en) 2001-11-15
ITMI20001051A0 (it) 2000-05-12
AU2001258395A1 (en) 2001-11-20
HRP20020893A2 (en) 2004-02-29
WO2001085174A1 (en) 2001-11-15
JP2004515454A (ja) 2004-05-27
IT1318514B1 (it) 2003-08-27
NO20025394D0 (no) 2002-11-11
PL366212A1 (en) 2005-01-24
SK16062002A3 (sk) 2003-04-01
TNSN01071A1 (fr) 2005-11-10
MXPA02011132A (es) 2003-04-25
MA26899A1 (fr) 2004-12-20
NO20025394L (no) 2003-01-13
HUP0302036A2 (hu) 2003-09-29
ITMI20001051A1 (it) 2001-11-12
AR028448A1 (es) 2003-05-07
EE200200632A (et) 2004-04-15
BG107257A (en) 2003-06-30

Similar Documents

Publication Publication Date Title
EA200201059A1 (ru) Препараты, содержащие глюкокортикостероидное лекарственное средство, для лечения бронхолегочных заболеваний
ATE308317T1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
ATE216575T1 (de) Treibgasmischung für eine aerosolzubereitung
ES2179910T3 (es) Modificacion cristalina del cdch, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
DK0918507T3 (da) Aerosolformuleringer
DE69231994D1 (de) Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
ATE343374T1 (de) Fluticasonpropionat arzneizubereitung
GB0016876D0 (en) Novel formulation
DK1244487T3 (da) Aerosolinhalator
DK1343472T3 (da) Thixotropisk næsespray
HUP9902675A2 (hu) Fluorozott-szénhidrogén-hajtógázt tartalmazó mometazon-furoát aeroszol
DK1161225T3 (da) Doseringsaerosol med isobutan som drivmiddel